Table 1 Overview of the patient cohort. The asterisk denotes p < 0.05 for the comparison between males and females. One participant logged 7 sessions and reported their gender as “unknown.” Their data was included in the total but not in either the male or female categories
Characteristic | Total (n = 184) | Males (n = 70) | Females (n = 113) |
|---|---|---|---|
Age (M ± SD) | 34.7 (± 8.0) | 37.2 (± 9.1) | 33.0 (± 6.7) |
Pre-medication anxiety score | 5.9 (± 2.2) | 6.0 (± 2.1) | 5.8 (± 2.3) |
Post-medication anxiety score | 2.2 (± 1.9) | 2.1 (± 1.6) | 2.3 (± 2.1) |
Average months anxiety users were using app | 3.6 (± 6.9) | 3.4 (± 7.2) | 3.6 (± 6.6) |
Average number of inhalations | 10.2 (± 6.8) | 11.1 (± 7)* | 9.7 (± 6.5) |
Average number of clinical indications per user | 5.4 (± 4.7) | 4.4 (± 3.6) | 6.1 (± 5.2) |
Average Efficacy (%) | 50.0 (± 0.23) | 50.3 (± 0.23) | 49.9 (± 0.23) |